Aeglea Biotherapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $51M | 3.1M | 16.76 |
| 2025-06-30 | $46M | 3.1M | 14.97 |
| 2025-03-31 | $47M | 2.9M | 16.14 |
| 2024-12-31 | $66M | 2.8M | 23.28 |
| 2024-09-30 | $74M | 2.5M | 29.41 |
| 2024-06-30 | $45M | 1.9M | 23.51 |
| 2024-03-31 | $19M | 497k | 37.93 |
| 2023-12-31 | $849k | 39k | 21.52 |
| 2023-09-30 | $405k | 33k | 12.25 |